Search

Displaying results 1931 - 1940 of 7479 in total
  1. Drug

    Tetracoccosporium paxianum

    go.drugbank.com/drugs/DB10849
    Approved

    Tetracoccosporium paxianum is a fungus which can provoke allergic reactions. Tetracoccosporium paxianum extract is used in allergenic testing.

  2. Drug

    Cladosporium herbarum

    go.drugbank.com/drugs/DB10865
    Approved

    Cladosporium herbarum is a fungus which can provoke allergic reactions. Cladosporium herbarum extract is used in allergenic testing.

  3. Drug

    Chrysonilia sitophila

    go.drugbank.com/drugs/DB10935
    Approved

    Chrysonilia sitophila is a fungus which can provoke allergic reactions. Chrysonilia sitophila extract is used in allergenic testing.

  4. Drug

    Aspergillus nidulans

    go.drugbank.com/drugs/DB11022
    Approved

    Aspergillus nidulans is a fungus which can provoke allergic reactions. Aspergillus nidulans extract is used in allergenic testing.

  5. Drug

    Dendryphiella vinosa

    go.drugbank.com/drugs/DB11025
    Approved

    Dendryphiella vinosa is a fungus which can provoke allergic reactions. Dendryphiella vinosa extract is used in allergenic testing.

  6. Drug

    Soy isoflavones

    go.drugbank.com/drugs/DB14101
    Approved

    Mixtures: D-Cal SoyCal, ISOFLAVONA DE SOYA + VITAMINA D300 UI +CITRATO DE CALCIO.
  7. Drug

    Rhodotorula rubra

    go.drugbank.com/drugs/DB10442
    Approved

    Rhodotorula rubra is a fungus which can provoke allergic reactions. Rhodotorula rubra is used in allergenic testing.

  8. Drug

    Rhodotorula mucilaginosa

    go.drugbank.com/drugs/DB10701
    Approved

    Rhodotorula mucilaginosa is a fungus which can provoke allergic reactions. Rhodotorula mucilaginosa is used in allergenic testing.

  9. Drug

    Candida tropicalis

    go.drugbank.com/drugs/DB10807
    Approved

    Candida tropicalis is a fungus which can provoke allergic reactions. Candida tropicalis is used in allergenic testing.

  10. Drug

    Saxagliptin

    go.drugbank.com/drugs/DB06335
    ApprovedInvestigational

    Saxagliptin (rINN) is an orally active hypoglycemic (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. FDA approved on July 31, 2009.